Credit Suisse Starts TriVascular Technologies (TRIV) at Outperform
Tweet
Share
E-mailGet Alerts TRIV Hot Sheet
Price: $5.87 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Credit Suisse initiated coverage on TriVascular Technologies (NASDAQ: TRIV) with an Outperform rating and a price target of $17.00.
For an analyst ratings summary and ratings history on TriVascular Technologies click here. For more ratings news on TriVascular Technologies click here.
Shares of TriVascular Technologies closed at $12.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
